Influence of CYP2C19 Genetic Polymorphisms and Helicobacter pylori Infection on Efficacy of Omeprazole Treatment in Patients With Nonvariceal Upper Gastrointestinal Tract Bleeding: A Prospective, Randomized Clinical Study

被引：0
|
作者：
Chwiesko, Adam
Charkiewicz, Radoslaw
Niklinski, Jacek
Milewski, Robert
Dabrowski, Andrzej
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S506 / S506
页数：1
相关论文
共 50 条
  • [1] CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori
    Tanigawara, Y
    Aoyama, N
    Kita, T
    Shirakawa, K
    Komada, F
    Kasuga, M
    Okumura, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (05) : 528 - 534
  • [2] Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection-a prospective, randomized, and controlled study
    Hong, J. B.
    Shu, X.
    Liu, D. S.
    Zhu, Y.
    Xie, C.
    Xie, Y.
    Zhang, K. H.
    Wang, A. J.
    Xiong, H. F.
    Chen, Y. X.
    Zhu, X.
    Lv, N. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 117 - 117
  • [3] CYP2C19 genotypes in Germany and influence on treatment of Helicobacter pylori infection
    Kirsch, C
    Schneider-Brachert, W
    Grossmann, D
    Stolte, M
    Lehn, N
    Miehlke, S
    GASTROENTEROLOGY, 2003, 124 (04) : A180 - A180
  • [4] The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Choi, Kee Don
    Song, Ho June
    Lee, Gin Hyug
    Kim, Jin-Ho
    GUT AND LIVER, 2010, 4 (02) : 201 - 206
  • [5] Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism
    Hokari, K
    Sugiyama, T
    Kato, M
    Saito, M
    Miyagishima, T
    Kudo, M
    Nishikawa, K
    Ishizuka, J
    Komatsu, Y
    Mizushima, T
    Kagaya, H
    Hige, S
    Takeda, H
    Asaka, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) : 1479 - 1484
  • [6] The influence of CYP2C19 on eradication of helicobacter pylori: a randomized study of lansoprazole and rabeprazole
    Lee, J. H.
    Jung, H-Y
    Choi, K-D
    Song, H-J
    Lee, G-H
    Kim, J-H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A23 - A23
  • [7] Effects of Helicobacter pylori status and CYP2C19 polymorphism on omeprazole efficacy in patients with gastroesophageal reflux disease
    Akiyama, J
    Fujisawa, T
    Koizuka, H
    Yoshinaga, S
    Serizawa, H
    Tashiro, J
    Kurosaka, K
    Muraoka, A
    Shoda, R
    Tamegai, Y
    Yamato, S
    Matsueda, K
    Uemura, N
    GASTROENTEROLOGY, 2003, 124 (04) : A229 - A229
  • [8] Correlation of CYP2C19 Genetic Polymorphisms With Helicobacter pylori Eradication in Patients With Cirrhosis and Peptic Ulcer
    Lay, Chii-Shyan
    Lin, Jiun-Rong
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2010, 73 (04) : 188 - 193
  • [9] The correlation of CYP2C19 genetic polymorphisms to Helicobacter pylori eradication in cirrhotic patients with peptic ulcer
    Lay, C-S
    Lin, J-R
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A20 - A20
  • [10] The influence of CYP2C19 polymorphism on the eradication of Helicobacter pylori:: A randomized study of lansoprazole and rabeprazole
    Jung, H. Y.
    Song, H. J.
    Choi, K. D.
    Chung, J. W.
    Kim, D. H.
    Kim, J. H.
    HELICOBACTER, 2007, 12 (04) : 429 - 429
12345